Page 59 - ARNM-2-4

Advances in Radiotherapy
& Nuclear Medicine Efficacy of stereotactic radiotherapy

Funding doi: 10.1056/NEJMoa0708857

This work was supported by grants from the National 3. Biller LH, Schrag D. Diagnosis and treatment of metastatic
Natural Science Foundation of China (grant numbers colorectal cancer: A review. JAMA. 2021;325(7):669-685.
82272736 and 82160467); the Research Foundation of doi: 10.1001/jama.2021.0106
the Science and Technology Department of Guangxi 4. Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: Treating
Province, China (grant number 2023GXNSFDA026009); cancer with specificity. Eur J Pharmacol. 2018;834:188-196.
the Research Foundation of the Health Department of
Guangxi Province, China (grant number S2018087); the doi: 10.1016/j.ejphar.2018.07.034
Autonomous Region Health Commission Self-funded 5. Li B, Chan HL, Chen P. Immune checkpoint inhibitors: Basics
Research Project (grant number Z-A20230472); and and challenges. Curr Med Chem. 2019;26(17):3009-3025.
the local science and technology development projects doi: 10.2174/0929867324666170804143706
organized under the guidance of the central government
(grant number ZY18057006). 6. Molla M, Fernandez-Plana J, Albiol S, et al. Limited liver
or lung colorectal cancer metastases. systemic treatment,
Conflict of interest surgery, ablation or SBRT. J Clin Med. 2021;10(10):2131.
doi: 10.3390/jcm10102131
The authors declare they have no competing interests.
7. Abel S, Lee S, Ludmir EB, Verma V. Principles and
Author contributions applications of stereotactic radiosurgery and stereotactic
body radiation therapy. Hematol Oncol Clin North Am.
Conceptualization: Min Kang 2019;33(6):977-987.
Investigation: Huan Dong, Rong Li, He-Qing Huang, Xing-
Hua Chen doi: 10.1016/j.hoc.2019.08.007
Methodology: Huan Dong, He-Qing Huang, Zi-Yan Zhou 8. Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery
Formal analysis: Huan Dong, Rong Li versus stereotactic body radiation therapy for stage I non-
Writing – original draft: Huan Dong, Rong Li small cell lung cancer: A comprehensive review. Cancer.
Writing – review & editing: All authors 2018;124(4):667-678.

Ethics approval and consent to participate doi: 10.1002/cncr.31196
9. Kimura T, Fujiwara T, Kameoka T, Adachi Y, Kariya S. The
The study protocol adhered to the ethical standards of the current role of Stereotactic Body Radiation Therapy (SBRT)
experimental committee of the responsible body and the in Hepatocellular Carcinoma (HCC). Cancers (Basel).
Declaration of Helsinki. This study was approved by the 2022;14(18):4383.
Ethics Review Committee of the First Affiliated Hospital of doi: 10.3390/cancers14184383
Guangxi Medical University (No. 2023-E257-01). Due to
the retrospective nature of the study, the need for patient 10. Myrehaug S, Sahgal A, Russo SM, et al. Stereotactic body
consent for inclusion was waived. radiotherapy for pancreatic cancer: Recent progress
and future directions. Expert Rev Anticancer Ther.
Consent for publication 2016;16(5):523-530.
Not applicable. doi: 10.1586/14737140.2016.1168698
11. Haque W, Butler EB, Teh BS. Stereotactic body radiation
Availability of data therapy for prostate cancer-a review. Chin Clin Oncol.
The datasets used and/or analyzed during the current 2017;6(Suppl 2):S10.
study are available from the corresponding author upon doi: 10.21037/cco.2017.06.05
reasonable request. 12. Goodman BD, Mannina EM, Althouse SK, Maluccio MA,

References Cárdenes HR. Long-term safety and efficacy of stereotactic
body radiation therapy for hepatic oligometastases. Pract
1. Rossi A, Di Maio M. Platinum-based chemotherapy in advanced Radiat Oncol. 2016;6(2):86-95.
non-small-cell lung cancer: Optimal number of treatment doi: 10.1016/j.prro.2015.10.011
cycles. Expert Rev Anticancer Ther. 2016;16(6):653-660.
13. Sogono P, Bressel M, David S, et al. Safety, efficacy, and
doi: 10.1586/14737140.2016.1170596 patterns of failure after Single-Fraction Stereotactic Body
2. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced Radiation Therapy (SBRT) for oligometastases. Int J Radiat
hepatocellular carcinoma. N Engl J Med. 2008;359(4):378-390. Oncol Biol Phys. 2021;109(3):756-763.

Volume 2 Issue 4 (2024) 7 doi: 10.36922/arnm.3391